Chadi Nabhan, MD, MBA, FACP; Yolaine Jeune-Smith, PhD; Amy Valley, PharmD; Bruce A Feinberg, DO

Researchers identified critical educational gaps that need to be addressed by manufacturers and policymakers in order for biosimilars to achieve their potential for lowering the cost of cancer care in the United States.